LARYNGEAL CANCER

Clinical trials for LARYNGEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new LARYNGEAL CANCER trials appear

Sign up with your email to follow new studies for LARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 1

New combo attack on tough head and neck cancers

Disease control Completed

This study tested whether adding a new immunotherapy drug (pembrolizumab) to the standard treatment of chemotherapy plus radiation could be safe and more effective for people with locally advanced head and neck cancer. All 59 participants received the combined treatment. The main…

Matched conditions: LARYNGEAL CANCER

Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

LARYNGEAL CANCER

Get alerted when new LARYNGEAL CANCER trials appear

New combo attack on tough head and neck cancers